[FOLD] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[FOLD] Amicus Therapeutics, Inc.
Announcement Date
06-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 57.13%
YoY- 68.81%
Quarter Report
FOLD's Result
FOLD's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 141,517 103,501 81,691 79,545 67,437 48,768 20,596 37.84%
PBT 6,785 -24,705 -29,263 -50,476 -63,284 -62,060 -159,214 -
Tax 13,514 3,128 4,023 -182 727 -251 -51 -
NP -6,729 -21,577 -33,286 -50,294 -64,011 -61,809 -159,163 -40.94%
Tax Rate -199.17% - - - - - - -
Total Cost 148,246 125,078 114,977 129,839 131,448 110,577 179,759 -3.15%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -4.75 -20.85 -40.75 -63.23 -94.92 -126.74 -772.79 -57.16%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.02 -0.07 -0.12 -0.19 -0.25 -0.24 -0.84 -46.33%
EPS Diluted -0.02 -0.07 -0.12 -0.19 -0.25 -0.24 -0.84 -46.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.